Kezar Life Sciences Inc (NASDAQ: KZR) closed the day trading at $0.95 down -0.27% from the previous closing price of $0.96. In other words, the price has decreased by -$0.0026 from its previous closing price. On the day, 623832 shares were traded.
Ratios:
For a better understanding of KZR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.83 and its Current Ratio is at 13.83. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.08.
On December 08, 2021, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $19.Wells Fargo initiated its Overweight rating on December 08, 2021, with a $19 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KZR now has a Market Capitalization of 69.63M and an Enterprise Value of -129.02M. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.92 while its Price-to-Book (P/B) ratio in mrq is 0.32. Its current Enterprise Value per Revenue stands at -18.43 whereas that against EBITDA is 1.50.
Stock Price History:
Over the past 52 weeks, KZR has reached a high of $5.70, while it has fallen to a 52-week low of $0.67. The 50-Day Moving Average of the stock is 0.9148, while the 200-Day Moving Average is calculated to be 1.3938.
Shares Statistics:
Over the past 3-months, KZR traded about 703.63K shares per day on average, while over the past 10 days, KZR traded about 1.07M shares per day. A total of 68.49M shares are outstanding, with a floating share count of 61.87M. Insiders hold about 15.01% of the company’s shares, while institutions hold 65.11% stake in the company. Shares short for KZR as of Feb 15, 2024 were 3M with a Short Ratio of 4.27, compared to 2.98M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 4.12% and a Short% of Float of 4.26%.
Earnings Estimates
Current recommendations for the stock of the company come from 5 analysts. On average, analysts expect EPS of -$0.38 for the current quarter, with a high estimate of -$0.34 and a low estimate of -$0.43, while EPS last year was -$0.25. The consensus estimate for the next quarter is -$0.3, with high estimates of -$0.28 and low estimates of -$0.34.
Analysts are recommending an EPS of between -$1.29 and -$1.46 for the fiscal current year, implying an average EPS of -$1.36. EPS for the following year is -$1.14, with 5 analysts recommending between -$0.9 and -$1.36.
